Bio-Rad Laboratories Net Profit Margin 2010-2023 | BIO.B

Current and historical net profit margin for Bio-Rad Laboratories (BIO.B) from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. Bio-Rad Laboratories net profit margin for the three months ending March 31, 2023 was .
Bio-Rad Laboratories Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-03-31 $2.78B $-0.19B -6.87%
2022-12-31 $2.80B $-3.63B -129.44%
2022-09-30 $2.81B $-6.02B -214.72%
2022-06-30 $2.87B $-1.93B -67.26%
2022-03-31 $2.90B $-0.09B -3.11%
2021-12-31 $2.92B $4.25B 145.54%
2021-09-30 $2.98B $6.67B 223.69%
2021-06-30 $2.88B $4.05B 140.73%
2021-03-31 $2.70B $4.11B 151.98%
2020-12-31 $2.55B $3.81B 149.80%
2020-09-30 $2.38B $3.52B 147.90%
2020-06-30 $2.29B $1.95B 84.83%
2020-03-31 $2.33B $1.58B 67.77%
2019-12-31 $2.31B $1.76B 76.04%
2019-09-30 $2.31B $0.38B 16.31%
2019-06-30 $2.29B $0.90B 39.49%
2019-03-31 $2.29B $0.57B 25.00%
2018-12-31 $2.29B $0.37B 15.94%
2018-09-30 $2.29B $1.28B 55.67%
2018-06-30 $2.28B $1.03B 45.12%
2018-03-31 $2.21B $0.77B 34.67%
2017-12-31 $2.16B $0.12B 5.65%
2017-09-30 $2.11B $0.02B 0.76%
2017-06-30 $2.09B $0.01B 0.58%
2017-03-31 $2.10B $0.03B 1.19%
2016-12-31 $2.07B $0.03B 1.21%
2016-09-30 $2.07B $0.09B 4.55%
2016-06-30 $2.03B $0.09B 4.58%
2016-03-31 $2.02B $0.10B 5.10%
2015-12-31 $2.02B $0.11B 5.40%
2015-09-30 $2.05B $0.10B 4.98%
2015-06-30 $2.11B $0.10B 4.60%
2015-03-31 $2.14B $0.10B 4.72%
2014-12-31 $2.18B $0.09B 4.14%
2014-09-30 $2.18B $0.08B 3.72%
2014-06-30 $2.15B $0.06B 2.88%
2014-03-31 $2.14B $0.07B 3.03%
2013-12-31 $2.13B $0.08B 3.66%
2013-09-30 $2.10B $0.09B 4.33%
2013-06-30 $2.10B $0.14B 6.72%
2013-03-31 $2.08B $0.15B 7.39%
2012-12-31 $2.07B $0.17B 7.97%
2012-09-30 $2.05B $0.18B 8.90%
2012-06-30 $2.06B $0.19B 8.97%
2012-03-31 $2.08B $0.18B 8.53%
2011-12-31 $2.07B $0.18B 8.63%
2011-09-30 $2.06B $0.19B 9.09%
2011-06-30 $2.01B $0.19B 9.24%
2011-03-31 $1.96B $0.18B 9.39%
2010-12-31 $1.93B $0.19B 9.65%
2010-09-30 $1.89B $0.16B 8.26%
2010-06-30 $1.88B $0.15B 7.99%
2010-03-31 $1.84B $0.15B 8.17%
2009-12-31 $1.78B $0.15B 8.13%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.988B $2.802B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $136.891B 8.36
GSK (GSK) United Kingdom $70.351B 9.82
QIAGEN (QGEN) Netherlands $10.229B 21.60
Ginkgo Bioworks Holdings (DNA) United States $3.712B 0.00
Biohaven (BHVN) United States $1.540B 0.00
Arcus Biosciences (RCUS) United States $1.505B 0.00
Emergent Biosolutions (EBS) United States $0.429B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.196B 0.00
Enzo Biochem (ENZ) United States $0.109B 0.00
SQZ Biotechnologies (SQZ) United States $0.016B 0.00